| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/13/1988 | EP0252588A2 Process for the isolation and purification of P. falciparum CS protein expressed in recombinant E. coli, and its use as a vaccine |
| 01/13/1988 | EP0252561A2 Expression and secretion vector in yeasts, useful for preparing heterologous proteins |
| 01/13/1988 | EP0252558A2 Element of dna of corynebacterium diphteriae with typical properties of an is insertion element |
| 01/13/1988 | EP0252531A1 Structural phosphoprotein (pp 150) of human cytomegalovirus, its preparation and use |
| 01/13/1988 | EP0252405A2 3-methoxy-4-hydroxyphenylglycol fluorescence polarization immunoassay |
| 01/13/1988 | EP0252404A2 5-Hydroxy-3-indoleacetic acid fluorescence polarization immunoassay |
| 01/13/1988 | EP0252392A2 Viral inactivation and purification of active proteins |
| 01/13/1988 | EP0252302A1 Major glycoprotein of human cytomegalo virus, its preparation and use |
| 01/13/1988 | EP0252146A1 Nuclear factors associated with transcriptional regulation. |
| 01/13/1988 | EP0252098A1 ASEXUAL BLOOD STAGE ANTIGENS OF $i(PLASMODIUM FALCIPARUM) |
| 01/13/1988 | CN87102799A Purification of pre-s hbsag by albumin polymerized serum affinity binding |
| 01/13/1988 | CN87102457A Immortalization of primary cells |
| 01/12/1988 | US4719288 Substituted 5-amino-4-hydroxyvaleryl derivatives |
| 01/12/1988 | US4719180 Genetic engineering |
| 01/12/1988 | US4719177 Genetic engineering |
| 01/12/1988 | US4719107 Immunomodulating medication based on Fc fragments of human IgG |
| 01/12/1988 | CA1231306A1 Purification of interferon |
| 01/07/1988 | EP0252064A2 Preparations active against pseudomonas aeruginosa infections, and process for their preparation |
| 01/07/1988 | EP0252060A1 DNA sequence, recombinant DNA molecules, and method for the production of the Newcastle disease virus fusion protein or equivalent polypeptides, products obtained and preparations containing them |
| 01/07/1988 | EP0252057A2 Serine protease inhibitors |
| 01/07/1988 | EP0251933A1 Peptide having antigenic properties isolated from the S. Mansoni 28KD proteingroup and its isolation process, monoclonal antibodies recognizing at least one epitope of that peptide, and uses in the induction of neutralizing antibodies synthesis |
| 01/07/1988 | EP0251874A1 Integration vectors for the expansion of factor IX in eucaryotic cells, cell lines obtained and method for their preparation |
| 01/07/1988 | EP0251843A1 Process for the preparation of factor VIII from mammalian cells |
| 01/07/1988 | EP0251842A1 Composite DNA sequence and its use in the production of a growth hormone |
| 01/07/1988 | EP0251744A2 Process for the genetic modification of yeast |
| 01/07/1988 | EP0251635A2 Monoclonal antibodies and method for detecting dioxins and dibenzofurans |
| 01/07/1988 | EP0251615A2 Method of chain combination |
| 01/07/1988 | EP0251612A2 Human monoclonal antibody to lymphadenopathy-associated virus |
| 01/07/1988 | EP0251579A2 Non-antibiotic marker system |
| 01/07/1988 | EP0251575A1 Hepatitis delta diagnostics and vaccines, their preparation and use |
| 01/07/1988 | EP0251554A2 A Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
| 01/07/1988 | EP0251534A1 Varicella-zoster virus as a live recombinant vaccine |
| 01/07/1988 | EP0251505A1 Recombinant purified protease nexin |
| 01/07/1988 | EP0251467A2 Compositions and methods of use for a major outer capsid protein (VP7) of rotavirus SA-11 |
| 01/07/1988 | EP0251460A2 Method for producing hepatitis B virus core antigen (HBcAg) in yeast |
| 01/07/1988 | EP0251449A2 Recombinant alveolar surfactant protein |
| 01/07/1988 | EP0251440A2 Human anti-Rhesus D producing heterohybridomas |
| 01/07/1988 | EP0251304A2 Glycosyl derivatives and use thereof |
| 01/07/1988 | EP0251244A2 Polypeptide and production thereof |
| 01/07/1988 | EP0251121A2 Process for inducing the formation of antibodies |
| 01/07/1988 | EP0251107A2 Improved fusion products |
| 01/07/1988 | EP0251065A2 Enhanced production of antibodies utilizing insolubilized immune complexes |
| 01/07/1988 | EP0251037A2 Novel human TNF polypeptide mutants and DNAs encoding said mutants |
| 01/07/1988 | EP0250501A1 A process for the preparation of a heat resistant non-bitter water-soluble peptide product, the product produced by the process, and nutrients, refreshments and dietetics comprising the product. |
| 01/07/1988 | EP0250486A1 Melphalan derivatives |
| 01/07/1988 | EP0137822B1 Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems |
| 01/07/1988 | EP0103000B1 Method for determination of tissue types coded by mhc genes |
| 01/06/1988 | CN86108975A Peptides corresponding to antigentic and immunogenic determinants of major nentralizing proteins of rotaviruses |
| 01/05/1988 | US4717670 Porcine beta FSH |
| 01/05/1988 | CA1231094A1 Fatty acid carriers for synthetic vaccines |
| 01/05/1988 | CA1231068A1 Cloning vectors for expression of exogenous protein |
| 01/05/1988 | CA1231067A1 Monoclonal antibody to peroxidase and hybridoma producing it |
| 01/05/1988 | CA1231051A1 Malaria associated antigen and preparing process thereof |
| 12/30/1987 | WO1987007958A1 Method for analyzing immunogenic peptide sequences with a view to the production of vaccines |
| 12/30/1987 | WO1987007910A1 Bradyrhizobium japonicum nodulation regulatory protein and gene |
| 12/30/1987 | WO1987007908A1 Vaccines containing epitopes of both the csp and a blood stage antigen of a plasmodium parasite |
| 12/30/1987 | WO1987007907A1 Process for the production of a protein |
| 12/30/1987 | WO1987007906A1 Variants of lav viruses, their dna- and protein-components and their uses, particularly for diagnostic purposes and for the preparartion of immunogenic compositions |
| 12/30/1987 | WO1987007896A1 T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen |
| 12/30/1987 | WO1987007840A1 A neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
| 12/30/1987 | WO1987007832A1 An acellular red blood cell substitute |
| 12/30/1987 | WO1987007472A3 A dna sequence encoding the mas oncogene, polypeptides encoded therefrom, and diagnostic and other methods based thereon |
| 12/30/1987 | CN87102304A Compounds for anti-dementia medicine and its usage |
| 12/30/1987 | CN87100463A Modification of plant viruses or their effects |
| 12/29/1987 | US4716235 Process for preparing N-[1(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline |
| 12/29/1987 | US4716222 Substrates for hydrolases |
| 12/29/1987 | US4716219 Adsorbent for protein purification |
| 12/29/1987 | US4716217 Hybrid lymphoblastoid-leukocyte human interferons |
| 12/29/1987 | US4716150 Oligo-and polypeptide antigens |
| 12/29/1987 | US4716148 Prothymosin alpha |
| 12/29/1987 | US4716147 Natriuretic polypeptides |
| 12/29/1987 | US4716122 Heterobifunctional photoactivatable compound as linker |
| 12/29/1987 | US4716117 Monoclonal antibodies to factor VIIIC |
| 12/29/1987 | US4716115 Derived nisin producing microorganisms, method of production and use and products obtained thereby |
| 12/29/1987 | US4716114 Procedure for the enhancement of the resistance to arsenite and arsenate of Thiobacillus ferrooxidans and Bacillus subtilis |
| 12/29/1987 | US4716112 Vectors for increased expression of cloned genes |
| 12/29/1987 | US4716104 Human cytomegalovirus-immunoglobulins |
| 12/29/1987 | CA1230841A1 POLYPEPTIDES WITH AN .alpha.-AMYLASE-INHIBITING ACTION, A PROCESS FOR THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PRODUCTS |
| 12/23/1987 | EP0250288A1 Process for preparing factor XIII from placenta |
| 12/23/1987 | EP0250261A1 Vaccines containing epitopes of both the CSP and a blood stage antigen of a plasmodium parasite |
| 12/23/1987 | EP0250253A2 T and B cell epitopes of the pre-S region of hepatitis B virus surface antigen |
| 12/23/1987 | EP0250119A2 Atherosclerotic anti-idiotype antibody immunoassay and reagents |
| 12/23/1987 | EP0250000A2 Polypeptides, their preparation and their use |
| 12/23/1987 | EP0249932A2 Automatic process for purifying physiologically active substance, apparatus for the same, and carrier with proteinaceous ligand fixed thereto to be used for the same |
| 12/23/1987 | EP0249877A2 Process for the preparation of an immunoreactive support material for heterogeneous immunological analysis |
| 12/23/1987 | EP0249854A2 Novel polypeptide |
| 12/23/1987 | EP0249676A2 Method for the expression of genes in plants |
| 12/23/1987 | EP0249635A1 Word recognition in a speech recognition system using data reduced word templates. |
| 12/23/1987 | EP0249611A1 T-lymphotrophic virus |
| 12/22/1987 | US4714768 Chemical intermediates |
| 12/22/1987 | US4714758 Mono- or dicarboxylic acids; for cosmetics, foods or medicines |
| 12/22/1987 | US4714708 Derivatives of cis, endo-2-azabicyclo[5.3.0]decane-3-carboxylic acid, and their use for treating hypertension |
| 12/22/1987 | US4714696 Novel derivatives of arginine vasopressin antagonists |
| 12/22/1987 | US4714683 Immunoassay, medical diagnosis |
| 12/22/1987 | US4714611 Stable composition of gamma-interferon |
| 12/22/1987 | CA1230591A1 PURIFIED TRANSFORMING GROWTH FACTOR-.beta. DERIVED FROM HUMAN PLATELETS AND PLACENTAS |
| 12/22/1987 | CA1230568A1 Antitumor antibiotic compound |
| 12/22/1987 | CA1230565A1 Monoclonal antibodies against non small cell lung cancer |
| 12/17/1987 | WO1987007646A2 Detection of point mutations in neu genes |
| 12/17/1987 | WO1987007644A1 TRANSLATION OF mRNA |